sTNFR1 and sTNFR2 can down-regulate inflammatory conditions by competing with membrane TNFR1 (mTNFR1) and mTNFR2 on TNFα binding and activities [55,56,57,58,59], and are detected in breast cancer patients [60,61,62,63,64,65]. Here, TNF is linked to breast carcinoma.